Sale!

AAGAB Gene Keratoderma Palmoplantar Punctate Type 1A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AAGAB gene is associated with the development of Keratoderma Palmoplantar Punctate Type 1A, a rare genetic skin disorder characterized by the appearance of small, punctate calluses on the palms of the hands and soles of the feet. These skin abnormalities typically emerge during childhood or adolescence and can lead to discomfort or pain, impacting the quality of life. The condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene is sufficient to cause the disorder.

A genetic test for Keratoderma Palmoplantar Punctate Type 1A focuses on identifying mutations in the AAGAB gene that are responsible for the condition. This test is crucial for confirming the diagnosis, understanding the inheritance pattern, and providing accurate genetic counseling for affected families. Additionally, it can help in the management and treatment planning of the condition by healthcare professionals.

At DNA Labs UAE, the test for the AAGAB gene mutation associated with Keratoderma Palmoplantar Punctate Type 1A is available for individuals who are suspected to have the condition based on clinical symptoms or have a family history of the disorder. The test cost is set at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced geneticists and laboratory technicians, ensuring accurate and reliable test results. This facility provides a comprehensive service that includes sample collection, DNA analysis, and a detailed report of the findings, along with counseling sessions to discuss the results and implications for the patient and their family.

Description

AAGAB Gene Keratoderma palmoplantar punctate type 1A Genetic Test

Test Name: AAGAB Gene Keratoderma palmoplantar punctate type 1A Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AAGAB Gene Keratoderma, palmoplantar, punctate type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AAGAB Gene Keratoderma, palmoplantar, punctate type 1A NGS Genetic DNA Test gene AAGAB

Test Details: AAGAB gene keratoderma, palmoplantar, punctate type 1A NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze the AAGAB gene for mutations associated with palmoplantar keratoderma, punctate type 1A. Palmoplantar keratoderma refers to a group of rare genetic disorders characterized by thickening of the skin on the palms of the hands and soles of the feet. Punctate keratoderma specifically refers to the presence of small, dot-like areas of thickened skin. The AAGAB gene is responsible for providing instructions for the production of the alpha- and gamma-adaptin-binding protein p34, which is involved in the formation of clathrin-coated vesicles. Mutations in the AAGAB gene have been linked to the development of palmoplantar keratoderma, punctate type 1A. The NGS genetic test involves collecting a sample of DNA, usually through a blood sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the AAGAB gene. The results of the test can help confirm a diagnosis of palmoplantar keratoderma, punctate type 1A and provide valuable information for genetic counseling and management of the condition. It is important to note that this test specifically focuses on mutations in the AAGAB gene and may not identify mutations in other genes that can also cause palmoplantar keratoderma or similar conditions. Therefore, additional genetic testing may be necessary depending on the specific clinical presentation and suspected genetic cause.

Test Name	AAGAB Gene Keratoderma palmoplantar punctate type 1A Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Osteology Dermatology Immunology Disorders
Doctor	Dermatologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for AAGAB Gene Keratoderma, palmoplantar, punctate type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AAGAB Gene Keratoderma, palmoplantar, punctate type 1A NGS Genetic DNA Test gene AAGAB
Test Details	AAGAB gene keratoderma, palmoplantar, punctate type 1A NGS genetic test is a diagnostic test that uses next-generation sequencing (NGS) technology to analyze the AAGAB gene for mutations associated with palmoplantar keratoderma, punctate type 1A. Palmoplantar keratoderma refers to a group of rare genetic disorders characterized by thickening of the skin on the palms of the hands and soles of the feet. Punctate keratoderma specifically refers to the presence of small, dot-like areas of thickened skin. The AAGAB gene is responsible for providing instructions for the production of the alpha- and gamma-adaptin-binding protein p34, which is involved in the formation of clathrin-coated vesicles. Mutations in the AAGAB gene have been linked to the development of palmoplantar keratoderma, punctate type 1A. The NGS genetic test involves collecting a sample of DNA, usually through a blood sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the AAGAB gene. The results of the test can help confirm a diagnosis of palmoplantar keratoderma, punctate type 1A and provide valuable information for genetic counseling and management of the condition. It is important to note that this test specifically focuses on mutations in the AAGAB gene and may not identify mutations in other genes that can also cause palmoplantar keratoderma or similar conditions. Therefore, additional genetic testing may be necessary depending on the specific clinical presentation and suspected genetic cause.